238 related articles for article (PubMed ID: 2424021)
1. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
Tschopp J; Mollnes TE
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
[TBL] [Abstract][Full Text] [Related]
2. The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains.
Young JD; Liu CC; Leong LG; Cohn ZA
J Exp Med; 1986 Dec; 164(6):2077-82. PubMed ID: 3537195
[TBL] [Abstract][Full Text] [Related]
3. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
4. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
Young JD; Rosse WF; Hasselkus-Light CS
Biochem Biophys Res Commun; 1990 Jan; 166(2):648-52. PubMed ID: 2302230
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the formation of the complement membrane-attack complex by a monoclonal antibody to the complement component C8 alpha subunit.
Abraha A; Luzio JP
Biochem J; 1989 Dec; 264(3):933-6. PubMed ID: 2695070
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
7. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
Zalman LS; Müller-Eberhard HJ
Mol Immunol; 1990 Jun; 27(6):533-7. PubMed ID: 1696352
[TBL] [Abstract][Full Text] [Related]
8. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.
Martin DE; Chiu FJ; Gigli I; Müller-Eberhard HJ
J Clin Invest; 1987 Jul; 80(1):226-33. PubMed ID: 3597774
[TBL] [Abstract][Full Text] [Related]
9. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
Deng J; Gold D; LoVerde PT; Fishelson Z
Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
[TBL] [Abstract][Full Text] [Related]
10. Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.
Scibek JJ; Plumb ME; Sodetz JM
Biochemistry; 2002 Dec; 41(49):14546-51. PubMed ID: 12463754
[TBL] [Abstract][Full Text] [Related]
11. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
[TBL] [Abstract][Full Text] [Related]
12. Studies of the association of the eighth and ninth components of human complement within the membrane-bound cytolytic complex.
Monahan JB; Stewart JL; Sodetz JM
J Biol Chem; 1983 Apr; 258(8):5056-62. PubMed ID: 6833292
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
Zalman LS; Wood LM; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
[TBL] [Abstract][Full Text] [Related]
14. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
Tschopp J; Masson D; Stanley KK
Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
[TBL] [Abstract][Full Text] [Related]
15. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
16. The terminal complement complex in sera deficient in the eighth component of complement (C8).
Mollnes TE; Lea T; Rogde S; Tedesco F
Scand J Immunol; 1986 Sep; 24(3):307-12. PubMed ID: 3749815
[TBL] [Abstract][Full Text] [Related]
17. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
[TBL] [Abstract][Full Text] [Related]
18. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
Young JD; Jiang S; Liu CC; Hasselkus-Light CS
J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
[TBL] [Abstract][Full Text] [Related]
19. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
Stewart JL; Kolb WP; Sodetz JM
J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
[TBL] [Abstract][Full Text] [Related]
20. Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex.
Kusunoki Y; Takekoshi Y; Nagasawa S
J Pharmacobiodyn; 1990 Jul; 13(7):454-60. PubMed ID: 2290128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
